Forsea Foods, an Israeli startup that develops cell-cultured seafood, announced that it has developed cultivated fish with the aid of its patented organoid technology. Organoids are 3D tissue structures that are derived from stem cells, which were previously used in developmental biology and medical research.

As its initial focus, the company plans to bring cultivated freshwater eels to the market but also stated that this technology can be used to make cultivated beef, pork, and chicken as well.

Organoid technology differs from other methods used in cellular agriculture for creating animal cells due to its ability to bypass the scaffolding stage. According to the company, these tissue cells grow in bioreactors in a similar manner to how they would grow inside their animal counterparts; hence the fish cells are able to form their native muscle and fat structures spontaneously.

Forsea Foods, founded in 2021, develops cell-cultured seafood by leveraging its patented organoid technology, which the company claims offers them distinct advantages over its competitors such as higher scalability and cost-effective production. The company intends to partner up with local and global players for the distribution of its initial cultivated eel product. Forsea Foods was part of The Kitchen FoodTech Hub, an Israeli startup incubator, and received its initial funding from the Israeli Innovation Authority (IIA).